Records containing: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-03A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers
-
CLINICAL_TRIALS study record update · 2026-04-27Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Ototoxicity Monitoring and Remote Audiometry
-
CLINICAL_TRIALS study record update · 2026-04-22Oropharynx (OPX) Biomarker Trial
-
CLINICAL_TRIALS study record update · 2026-04-20Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery
-
CLINICAL_TRIALS study record update · 2026-04-15Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2026-04-13Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2 Study of Ipatasertib in Combination With Pembrolizumab for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers
-
CLINICAL_TRIALS study record update · 2026-04-03Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
-
CLINICAL_TRIALS study record update · 2026-03-05Phase III Randomized Trial of Immunotherapy With or Without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2026-03-04Phase 1b Study of TMV Vaccine Therapy Alone and TMV Vaccine Plus Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase II Trial Of Lovastatin And Pembrolizumab In Patients With RM HNSCC (LAPP)
-
CLINICAL_TRIALS study record update · 2025-02-12RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-12-13Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2024-07-25Phase II Trial of Xevinapant and Chemoradiotherapy in Adjuvant Treatment for Patients With Head and Neck Squamous Cell Carcinoma With High Risk Pathologic Features
-
CLINICAL_TRIALS study record update · 2024-06-28A Phase II Study of Sodium Thiosulfate (STS) for Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) Undergoing Concurrent Chemoradiation With Cisplatin
-
CLINICAL_TRIALS study record update · 2023-01-06Effects of a Pneumatic Compression Device in Post-Chemoradiation Head and Neck Cancer Population
-
CLINICAL_TRIALS study record update · 2021-12-03Primary Surgery Vs Primary Chemoradiation for Oropharyngeal Cancer (Scope Trial) - A Phase II/III Integrated Design Randomized Control Trial